ResearcherHomi Bhabha National InstituteActive in the last 2 years
Manish Suresh BHANDARE
Matched on ORCID iD 0000-0002-5390-130X; OpenAlex author ID A5070605247. Sources: OpenAlex.
Their work
- Papers
- 14 (first author 1, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 56
2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers · 2025: 4 papers · 2026: 1 paper
Papers 14
- Financial toxicity among gastric and pancreatic cancer survivors in India and its impact on quality of life. Co-author DOI 10.1016/j.jcpo.2026.100730↗
- Utility of Surgical Apgar Score in Predicting Post-operative Complications After Whipple Procedure in Pancreatic Cancer Patients. Co-author DOI 10.1007/s13193-024-02151-1↗
- Financial burden due to distance traveled to access treatment from specialized cancer hospitals in public sector in India: a case study of patients treated for… Last author DOI 10.1016/j.jcpo.2025.100632↗
- Periarterial Divestment and Triangle Clearance in Pancreatic Cancer: A Video Vignette. Last author DOI 10.1245/s10434-024-16542-9↗
- ASO Author Reflections: Arterial Divestment: A Viable and Safe Option for Resection of Locally Advanced Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-16924-7↗
- Differential impact of incrementally elevated CA 19-9 levels on prognosis of resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hpb.2024.06.004↗
- Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Results From an International Multicenter Study. Co-author DOI 10.1200/jco.23.02313↗
- Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) - Results from the Multicentre Indian Pancreatic & Periampull… Co-author DOI 10.1007/s12029-023-00936-1↗
- Neoadjuvant therapy in borderline resectable pancreatic cancer: Outcomes in the era of changing practices and evolving evidence. Co-author DOI 10.1016/j.surg.2021.10.018↗
- Minimally invasive surgery for pancreatic cancer-are we there yet?-a narrative review. Co-author DOI 10.21037/cco-21-131↗
- Twelve Hundred Consecutive Pancreato-Duodenectomies from Single Centre: Impact of Centre of Excellence on Pancreatic Cancer Surgery Across India. Last author DOI 10.1007/s00268-019-05235-0↗
- Correction to: Twelve Hundred Consecutive Pancreato-Duodenectomies from Single Centre: Impact of Centre of Excellence on Pancreatic Cancer Surgery Across India. Last author DOI 10.1007/s00268-020-05519-w↗
- Cutting-edge strategies for borderline resectable pancreatic cancer. First author DOI 10.1002/ags3.12254↗
- Improved Outcomes in 394 Pancreatic Cancer Resections: the Impact of Enhanced Recovery Pathway. Co-author DOI 10.1007/s11605-018-3809-7↗
Closest collaborators
The 25 strongest of 56 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shailesh Vinayak Shrikhande · 14 shared papers, 2018–2026 · strength 3.00
- Paper Periarterial Divestment and Triangle Clearance in Pancreatic Cancer: A Video Vignette. DOI 10.1245/s10434-024-16542-9↗
- Paper ASO Author Reflections: Arterial Divestment: A Viable and Safe Option for Resection of Locally Advanced Pancreatic Canc… DOI 10.1245/s10434-025-16924-7↗
- Paper Financial toxicity among gastric and pancreatic cancer survivors in India and its impact on quality of life. DOI 10.1016/j.jcpo.2026.100730↗
- Vikram Anil Chaudhari · 10 shared papers, 2018–2025 · strength 1.90
- Paper Periarterial Divestment and Triangle Clearance in Pancreatic Cancer: A Video Vignette. DOI 10.1245/s10434-024-16542-9↗
- Paper ASO Author Reflections: Arterial Divestment: A Viable and Safe Option for Resection of Locally Advanced Pancreatic Canc… DOI 10.1245/s10434-025-16924-7↗
- Paper Minimally invasive surgery for pancreatic cancer-are we there yet?-a narrative review. DOI 10.21037/cco-21-131↗
- Shravan Nadkarni · 2 shared papers, 2025 · strength 0.73
- Vandana Agarwal · 4 shared papers, 2018–2025 · strength 0.62
- Paper Utility of Surgical Apgar Score in Predicting Post-operative Complications After Whipple Procedure in Pancreatic Cancer… DOI 10.1007/s13193-024-02151-1↗
- Paper Twelve Hundred Consecutive Pancreato-Duodenectomies from Single Centre: Impact of Centre of Excellence on Pancreatic Ca… DOI 10.1007/s00268-019-05235-0↗
- Paper Correction to: Twelve Hundred Consecutive Pancreato-Duodenectomies from Single Centre: Impact of Centre of Excellence o… DOI 10.1007/s00268-020-05519-w↗
- Vikas S. Ostwal · 3 shared papers, 2022–2024 · strength 0.47
- Paper Differential impact of incrementally elevated CA 19-9 levels on prognosis of resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2024.06.004↗
- Paper Neoadjuvant therapy in borderline resectable pancreatic cancer: Outcomes in the era of changing practices and evolving … DOI 10.1016/j.surg.2021.10.018↗
- Paper Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) - Results from the Mu… DOI 10.1007/s12029-023-00936-1↗
- Anant Ramaswamy · 3 shared papers, 2022–2024 · strength 0.47
- Paper Differential impact of incrementally elevated CA 19-9 levels on prognosis of resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2024.06.004↗
- Paper Neoadjuvant therapy in borderline resectable pancreatic cancer: Outcomes in the era of changing practices and evolving … DOI 10.1016/j.surg.2021.10.018↗
- Paper Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) - Results from the Mu… DOI 10.1007/s12029-023-00936-1↗
- Rajesh S. Shinde · 3 shared papers, 2019–2020 · strength 0.39
- Paper Cutting-edge strategies for borderline resectable pancreatic cancer. DOI 10.1002/ags3.12254↗
- Paper Twelve Hundred Consecutive Pancreato-Duodenectomies from Single Centre: Impact of Centre of Excellence on Pancreatic Ca… DOI 10.1007/s00268-019-05235-0↗
- Paper Correction to: Twelve Hundred Consecutive Pancreato-Duodenectomies from Single Centre: Impact of Centre of Excellence o… DOI 10.1007/s00268-020-05519-w↗
- Abhishek Anand · 1 shared paper, 2026 · strength 0.36
- Reena Z. Engineer · 2 shared papers, 2022–2024 · strength 0.35
- Paper Differential impact of incrementally elevated CA 19-9 levels on prognosis of resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.hpb.2024.06.004↗
- Paper Neoadjuvant therapy in borderline resectable pancreatic cancer: Outcomes in the era of changing practices and evolving … DOI 10.1016/j.surg.2021.10.018↗
- Mohit Pandey · 1 shared paper, 2025 · strength 0.33
- Nilanjana Howbora · 1 shared paper, 2025 · strength 0.28
- Vijaya P. Borkar Patil · 1 shared paper, 2025 · strength 0.28
- Abhishek Mitra · 2 shared papers, 2018–2022 · strength 0.22
- Bhawna Sirohi · 1 shared paper, 2022 · strength 0.14
- Matthew H. G. Katz · 1 shared paper, 2024 · strength 0.13
- Floortje van Oosten · 1 shared paper, 2024 · strength 0.13
- Nader N Hanna · 1 shared paper, 2024 · strength 0.13
- Chanjuan Shi · 1 shared paper, 2024 · strength 0.13
- Myrte Gorris · 1 shared paper, 2024 · strength 0.13
- Lily V. Saadat · 1 shared paper, 2024 · strength 0.13
- Peter J. Allen · 1 shared paper, 2024 · strength 0.13
- Jin Peng He · 1 shared paper, 2024 · strength 0.13
- Lois A. Daamen · 1 shared paper, 2024 · strength 0.13
- Marco Del Chiaro · 1 shared paper, 2024 · strength 0.13
- Shuichi Watanabe · 1 shared paper, 2024 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.